The MSFHR Innovation to Commercialization (I2C) Program provides funding support to help BC health researchers advance their products or technologies towards practical application to improve health outcomes, benefit society, and enrich the health innovation ecosystem in BC through contributing to talent development and a strong, sustainable knowledge economy.
- Applications open: Early January 2018
- Letter of intent deadline: February 16, 2018, 4:30 p.m. PT
- Applicants who are interested in pursuing Mitacs Accelerate funding will need to indicate this at the LOI stage and subsequently submit a draft internship work plan to MSFHR.
- Full application deadline: April 3, 2018, 4:30 p.m. PT
- Anticipated notice of funding decision: Late June 2018
- Anticipated start of funding: August 1, 2018
New for 2018: Supplemental funding for experiential training offered in partnership with Mitacs
MSFHR is partnering with Mitacs to offer I2C award applicants the opportunity to apply for supplemental funding to support and train graduate students and post-doctoral fellows involved with their I2C projects, and foster collaboration between researchers, students and industry.
Using an integrated application and MSFHR’s peer review process, qualified I2C applicants will have expedited access to Mitacs Accelerate funding, which supports experiential training internships, with the funded interns splitting their time between their academic environment and a non-academic partner organization.
Also new for 2018, based on feedback and learnings from the inaugural I2C competition, we have incorporated additional commercialization plan guidance for applicants and continue to work with university partners and other research ecosystem stakeholders to build regional capacity and strengthen gender diversity among I2C applicants.
- Annual intake.
- Award term of up to four years.
- Phase I: $150,000/annum for two years.
- Phase II: An additional two years of funding of up to $75,000 per annum contingent on successful renewal review and match funding support from a non-BC government source.
- Focus of translational research must be at or past active research and development for proof-of-principle, but not past the level of a successfully-demonstrated product or technology (see section 7, Technological Readiness).
- I2C funding can be used to support activities directly related to implementation of a commercialization plan. This may include both salary support and commercialization-related expenses.
- Eligible to researchers who hold an appointment at an eligible BC university, health authority or research institute and conduct research with a clear link to human health.
- Mitacs Accelerate funding:
- In order to facilitate Mitacs Accelerate internships, Mitacs will work with interested applicants to determine how an internship could be designed when the I2C project is being developed.
- Interested applicants should contact their regional Mitacs Business Development representative for more information and instructions on including Mitacs Accelerate internships in the MSFHR I2C application.
- Partnership opportunities available.
Application resources (PDF)
- Guidelines (updated Jan 11, 2018)
- Instructions (updated Jan 11, 2018)
- Evaluation Criteria (updated Jan 11, 2018)
- Conditions of Award (updated Jan 11, 2018)
- FAQ (updated Jan 11, 2018)